Core Laboratories Inc. filed an 8-K on October 28, 2026, reporting its third-quarter 2026 financial results and announcing a quarterly cash dividend of $0.01 per share of common stock.

Key Highlights

  • Q3 2026 results disclosed: Core Laboratories issued a press release on October 28, 2026, announcing its financial results for the third quarter of 2026.
  • Quarterly cash dividend declared: The company announced a quarterly cash dividend of $0.01 per share of common stock.
  • Record date set: Shareholders of record as of November 9, 2026 will be eligible for the dividend.
  • Payment date confirmed: The dividend is payable on November 30, 2026.
  • Signed by CFO: The filing was signed by Christopher S. Hill, Chief Financial Officer, on October 28, 2026.

Core Laboratories Announces Q3 2026 Earnings and Dividend Details

Core Laboratories Inc. (NYSE:CLB), a Delaware-incorporated company headquartered at 6316 Windfern Road, Houston, TX 77040, filed a current report on October 28, 2026, covering two disclosures. Under Item 2.02, the company disclosed that it issued a press release on October 28, 2026, announcing its financial results for the third quarter of 2026. The full text of that press release was attached as Exhibit 99.1.

Under Item 7.01, the filing disclosed, pursuant to Regulation FD, that the same press release also contained an announcement of a quarterly cash dividend. According to the filing, the dividend is $0.01 per share of common stock, with a record date of November 9, 2026, and a payment date of November 30, 2026. The company's common stock carries a par value of $0.01 and is listed on the New York Stock Exchange under the ticker symbol CLB.

The filing noted that the information contained in the report and the attached exhibit "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934." The report was signed on behalf of Core Laboratories Inc. by Christopher S. Hill, Chief Financial Officer, on October 28, 2026. The press release itself, which contains the detailed financial results, is incorporated by reference as Exhibit 99.1 and is described in the filing as intended to be furnished rather than filed.

What Was Disclosed

Core Laboratories filed an 8-K on October 28, 2026, reporting Q3 2026 financial results and a quarterly cash dividend of $0.01 per share, with a record date of November 9, 2026, and a payment date of November 30, 2026.